Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KV2U
|
|||
| Drug Name |
P-toluenesulfonate derivative 1
|
|||
| Synonyms |
PMID28594589-Compound-TABLE3c4
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
JIANGSU HENGRUI MEDICINE CO., LTD
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ERK activator kinase (MEK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | ERK activator kinase (MEK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MEK inhibitors in oncology: a patent review (2015-Present).Expert Opin Ther Pat. 2017 Aug;27(8):887-906. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.